Clopidogrel (Plavix) may compete with prasugrel (Effient)

Clopidogrel (Plavix) may compete with prasugrel (Effient).

They're both in the same class...thienopyridines.

Prasugrel is currently investigational in Canada. It will likely be approved in the U.S. early as this summer.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get quote